The Evolution of Beer Yeast

Sequencing more than 150 yeast genomes, scientists describe distinct lineages cultivated by humans for making beer and wine.

Written byBen Andrew Henry
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, QUINN DOMBROWSKIFor thousands of years, humans have harnessed the natural metabolic activity of yeast, a microorganism that breaks down sugars into alcohol, to make beer and wine. Our taste for fermented drinks led to the domestication of certain strains of yeast, and a paper published last week (September 8) in Cell lays out some of this evolutionary history.

A team of scientists from University of Leuven, Vlaams Instituut voor Biotechnologie (VIB), and Ghent University in Belgium sequenced the genomes of 157 strains of Saccharomyces cerevisiae yeasts that are used to make beer, wine, bread, and other products on commercial scales. The team found five sublineages, with distinct phenotypes from wild yeasts, that have been cultivated for human use.

The researchers also dated the earliest cultivated yeast strains to the 1500s, which is likely a consequence of beer production in Europe moving from pubs into monasteries, where brewers began to retain yeast from one batch of beer to the next, reported Scientific American. As these early brewers fine-tuned their recipes, they also selected for favorable yeast strains. Domesticated yeasts have a greater capacity to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies